Compare Freshworks Inc (FRSH) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs Novartis AG — how do they compare? Freshworks Inc trades at $11.86 (market cap $3.31B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 89.2× Freshworks Inc's market cap, and Novartis AG pays a 3.07% dividend while Freshworks Inc pays none. Which is the better fit depends on your goals.
| FRSH | NVS | |
|---|---|---|
Market Cap | $3.31B | $295.37B |
Sector | Technology | Health |
52-Week High | $13.97 | $168.62 |
52-Week Low | $6.88 | $119.31 |
Enterprise Value | $2.68B | $336.69B |
Dividend Yield | — | 3.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
